Philippe Legenne
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
Papers in
- Oncology 20
- Peptidase Inhibition and Analysis 7
- Cancer Immunotherapy and Biomarkers 5
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 3
-
- Melanoma and MAPK Pathways 5
- Protein Degradation and Inhibitors 3
- Co-authors
- Stephen Lane (6 shared papers)Georgina V. Long (5 shared papers)Keith T. Flaherty (3 shared papers)Dirk Schadendorf (2 shared papers)Antoni Ribas (2 shared papers)Carmen Mak (2 shared papers)Paul Nathan (2 shared papers)Jean‐Jacques Grob (3 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Blood (2 papers)European Journal of Cancer (2 papers)British Journal of Clinical Pharmacology (1 paper)JCO Precision Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Philippe Legenne
28 papers receiving 522 citations
Peers
Comparison fields: 5 of 49
- Otorhinolaryngology 81
- Oncology 303
- Molecular Biology 257
- Pulmonary and Respiratory Medicine 94
- Infectious Diseases 42
Countries citing papers authored by Philippe Legenne
This map shows the geographic impact of Philippe Legenne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Legenne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Legenne more than expected).
Fields of papers citing papers by Philippe Legenne
This network shows the impact of papers produced by Philippe Legenne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Legenne. The network helps show where Philippe Legenne may publish in the future.
Co-authors
The 25 scholars most cited alongside Philippe Legenne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 221 | |
| 2 | 2012 | 94 | |
| 3 | Lack of activity of amphotericin B in systemic murine fusarial infection. | 1992 | 47 |
| 4 | 2013 | 29 | |
| 5 | 2020 | 25 | |
| 6 | 2014 | 22 | |
| 7 | 2010 | 22 | |
| 8 | 2015 | 20 | |
| 9 | 2024 | 6 | |
| 10 | 2013 | 6 | |
| 11 | 2010 | 6 | |
| 12 | 2022 | 5 | |
| 13 | 2016 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2013 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2025 | 2 |
About Philippe Legenne
Philippe Legenne is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Radiology, Nuclear Medicine and Imaging, having authored 30 papers that have together received 541 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), HER2/EGFR in Cancer Research (5 papers), Melanoma and MAPK Pathways (5 papers), Lung Cancer Treatments and Mutations (5 papers), Protein Degradation and Inhibitors (3 papers), Cancer Treatment and Pharmacology (3 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Otorhinolaryngology (81 citations), Oncology (303 citations), Molecular Biology (257 citations), Pulmonary and Respiratory Medicine (94 citations) and Infectious Diseases (42 citations). Philippe Legenne has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Stephen Lane, Georgina V. Long, Keith T. Flaherty, Dirk Schadendorf, Antoni Ribas, Carmen Mak, Paul Nathan, Jean‐Jacques Grob, Michael A. Davies and Caroline Robert. Their work appears in journals such as Journal of Clinical Oncology, Blood, European Journal of Cancer, British Journal of Clinical Pharmacology and JCO Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.